Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'

23 points by 1659447091 76 days ago text.npr.org 8 comments
Summary not yet generated for this article.

Comments (8 of ) ⌛

Loading more comments... ⌛
Scroll down to load more comments
No comments available.
Type to search HN and engineering blog articles
Press Escape to close  |  ↑↓ to navigate  |  Enter to open